Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:51 AM UTC
| NCT Number | NCT05640999 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE2 |
| Target Enrollment | 393 participants |
| Active Locations | 77 sites in the US |
| Sponsor | Canadian Cancer Trials Group |
| Last Updated on CT.gov | October 14, 2026 (2 days ago) |
As of October 16, 2026: Clinical trial NCT05640999 is currently recruiting participants. This phase2 study for endometrial cancer is actively seeking new participants at 77 locations across the United States. The study is sponsored by Canadian Cancer Trials Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05640999 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 77 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05640999 was last updated 2 days ago (October 14, 2026). HelloStudys verifies this status automatically.